NED is associated with increased tumor aggressiveness, resistance to conventional therapies, and poor prognosis in various malignancies.16) The expression of neuroendocrine markers, such as chromogranin A, has been shown to enhance tumor plasticity and invasiveness by secreting biologically active substances. The gene discussed is CHGA; the disease is neoplasm.